Abstract
Objective This study aimed to investigate the relationship between different types of fatty acid intake and cataract incidence using data from NHANES 2005-2008, with the goal of providing scientific evidence for guiding fatty acid supplementation in the elderly and preventing cataracts. Methods A total of 2,536 participants were selected from the 2005-2008 National Health and Nutrition Examination Survey (NHANES) database. Student’s t-test and Pearson chi-square test were used to analyze the correlation between baseline data, characteristic data, and all dietary fatty acid intakes with cataract incidence. Weighted multivariate logistic regression was employed to examine the relationship between all fatty acid intakes and cataracts. Quartile regression analysis was used to evaluate the effect of dodecanoic acid on cataracts at different intake levels. Results After adjusting for covariates, significant differences were observed in the daily intakes of total fat (69.80 g vs. 62.46 g, p=0.005), total saturated fatty acids (23.06 g vs. 20.60 g, p=0.002), total monounsaturated fatty acids (25.53 g vs. 22.76 g, p=0.009), and total polyunsaturated fatty acids (15.16 g vs. 13.61 g, p=0.014) between the two groups. When cataract was used as the outcome variable, a significant negative correlation was found between daily dodecanoic acid intake and cataract in the weighted multivariate logistic regression model (Model 1: OR=0.79, 95% CI=0.65-0.97; Model 2: OR=0.80, 95% CI=0.65-0.97; Model 3: OR=0.81, 95% CI=0.66-0.99). In the quartile regression analysis, the fourth quartile of daily dodecanoic acid intake was negatively correlated with cataract incidence in all models (Model 1: OR=0.58, 95% CI=0.39-0.86; Model 2: OR=0.58, 95% CI=0.39-0.86; Model 3: OR=0.60, 95% CI=0.40-0.91). Conclusion Increasing the daily intake of dodecanoic acid in the diet may reduce the likelihood of cataract development. Appropriate supplementation of dodecanoic acid in the daily diet can help prevent the occurrence and progression of cataracts.
Competing Interest Statement
The authors have declared that no competing interests exist.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Jiamusi University
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos